Beyond Traditional Placebo Controls in Rare Disease Clinical Trials: New cTAP Evidence Supports Patient-Centric Alternatives

/PRNewswire/ -- The Collaborative Trajectory Analysis Project (cTAP), a global coalition in rare disease, has announced evidence to support patient-centric...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,London ,City Of ,Francesco Muntoni ,James Signorovitch ,Principal At Analysis Group ,Institute Of Child Health ,Collaborative Trajectory Analysis Project ,Duchenne Muscular Dystrophy ,Professor Francesco Muntoni ,Paediatric Neurology ,Ormond Street Institute ,Child Health ,Great Ormond Street Hospital ,Managing Principal ,Executive Director ,Collaborative Trajectory Analysis Project Ctap ,